Howard M Fillit, MD

img_Howard M Fillit
CLINICAL PROFESSOR | Geriatrics and Palliative Medicine
CLINICAL PROFESSOR | Neuroscience
CLINICAL PROFESSOR | Medicine
Are you a patient?
Specialties
Internal Medicine, Geriatrics, Palliative Care

BA, Cornell University

MD, SUNY Upstate Medical University College of Medicine

Residency, Internal Medicine, Beth Israel Medical Center-Petrie Division

Fellowship, Nephrology, Hospital for Special Surgery

Certifications

American Board of Internal Medicine
Publications

Selected Publications

GWAS of Tau-Neurodegeneration Mismatch Identifies New Risk Loci for Susceptibility to Tau. Fardin Nabizadeh, Hanieh Mohamadi, Michael W. Weiner, Paul Aisen, Ronald Petersen, Clifford R. Jack, William Jagust, John Q. Trojanowski, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew J. Saykin, John Morris, Leslie M. Shaw, Zaven Khachaturian, Greg Sorensen, Lew Kuller, Marcus Raichle, Steven Paul, Peter Davies, Howard Fillit, Franz Hefti, David Holtzman, Marek M. Mesulam, William Potter, Peter Snyder, Adam Schwartz, Tom Montine, Ronald G. Thomas, Michael Donohue, Sarah Walter, Devon Gessert, Tamie Sather, Gus Jiminez, Danielle Harvey, Matthew Bernstein, Paul Thompson, Norbert Schuff, Bret Borowski, Jeff Gunter, Matt Senjem, Prashanthi Vemuri, David Jones, Kejal Kantarci, Chad Ward, Robert A. Koeppe, Norm Foster, Eric M. Reiman, Kewei Chen, Hillel Grossman. CNS Neuroscience and Therapeutics

Biomarkers in Alzheimer's disease clinical trials: 2025. Amanda M.Leisgang Osse, Yadi Zhou, Jefferson W. Kinney, Andrew Hooyman, Ayan Sengupta, Jorge Fonseca, Aaron H. Burstein, Meriel Owen, Laura Nisenbaum, Howard M. Fillit, Feixiong Cheng, Jeffrey L. Cummings. Alzheimer's and Dementia: Translational Research and Clinical Interventions

Plasma p-tau217 and glucose metabolism correlate in neocortical association areas in Alzheimer's disease. Lauren N. Koenig, Hanna Huber, Anjalika Chongtham, Guglielmo Di Molfetta, Randolph D. Andrews, Ana Lukic, Neeva Shafiian, Howard M. Fillit, Kaj Blennow, Nicholas J. Ashton, Henrik Zetterberg, Dawn C. Matthews, Ana C. Pereira. Brain Communications

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Fillit during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Alector
  • LifeWorx
  • Eli Lilly and Company

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.